Srinag Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.50 M
as on 11-12-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -22.87%
(FY 2022)
- Profit 129.92%
(FY 2022)
- Ebitda 198.48%
(FY 2022)
- Net Worth 39.52%
(FY 2022)
- Total Assets 39.73%
(FY 2022)
About Srinag Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasulu Kavuturu and Nageswara Pinneti serve as directors at the Company.
- CIN/LLPIN
U24299TG2017PTC119111
- Company No.
119111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2017
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Srinag Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasulu Kavuturu  | Managing Director | 25-Aug-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nageswara Pinneti | Director | 25-Aug-2017 | Current |
Financial Performance of Srinag Pharma.
Srinag Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 22.87% decrease. The company also saw a substantial improvement in profitability, with a 129.92% increase in profit. The company's net worth Soared by an impressive increase of 39.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srinag Pharma?
In 2021, Srinag Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Svr Drugs Private LimitedActive 14 years 3 monthsSrinivasulu Kavuturu and Nageswara Pinneti are mutual person
- S.V.R. Laboratories Private LimitedActive 21 years 3 months
Srinivasulu Kavuturu and Nageswara Pinneti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Srinag Pharma?
Unlock and access historical data on people associated with Srinag Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srinag Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srinag Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
